Endothelin enhances the contractile responsiveness of adult rat ventricular myocytes to calcium by a pertussis toxin-sensitive pathway

The Journal of Clinical Investigation
R A KellyT W Smith

Abstract

It has long been assumed that the primary influences regulating cardiac contractility are the extent of mechanical loading of muscle fibers and the activity of the autonomic nervous system. However, the vasoactive peptide endothelin, initially found in vascular endothelium, is among the most potent positively inotropic agents yet described in mammalian myocardium. In isolated adult rat ventricular cells, endothelin's action was slow in onset but very long lasting with an EC50 of 50 pM that approximates the reported KD of the peptide for its receptor in rat heart. When the calcium activity of the buffer superfusing isolated single fura-2-loaded myocytes paced at 1.5 Hz was varied from 0.1 to 0.9 mM [Ca2+]o, 100 pM endothelin increased contractile amplitude with no significant change in diastolic or systolic [Ca2+]i, thus appearing to sensitize the myofilaments to intracellular calcium. Pertussis toxin, or prior exposure to a beta-adrenergic agonist, reduced or abolished the increase in myocyte contractility induced by endothelin. This novel and potent pharmacologic action of endothelin points to the potential importance of local, paracrine factors, perhaps derived from microvascular endothelium or endocardium, in the control of ...Continue Reading

References

Dec 1, 1978·The Journal of General Physiology·G B McClellan, S Winegrad
Aug 30, 1988·Biochemical and Biophysical Research Communications·Y FukudaT Masaki
Nov 1, 1988·Pflügers Archiv : European journal of physiology·T IshikawaT Masaki
Jan 1, 1989·Journal of Cardiovascular Pharmacology·R F PowerJ M Polak
Sep 15, 1989·Biochemical and Biophysical Research Communications·R A Lew, A J Baertschi
Jan 16, 1989·Biochemical and Biophysical Research Communications·T J ResinkF R Bühler
Jan 16, 1989·Biochemical and Biophysical Research Communications·P A MarsdenT A Brock
May 15, 1989·Biochemical and Biophysical Research Communications·Y HirataF Marumo
Jun 30, 1989·Biochemical and Biophysical Research Communications·H WatanabeK Murakami
Sep 15, 1989·Biochemical and Biophysical Research Communications·R GalronM Sokolovsky
Feb 28, 1989·Biochemical and Biophysical Research Communications·C S MoravecM Bond
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·A InoueT Masaki
Apr 25, 1989·European Journal of Pharmacology·A M ShahA H Henderson
Aug 3, 1989·European Journal of Pharmacology·T KitayoshiN Shimamoto
Dec 6, 1988·European Journal of Pharmacology·J R HuR E Lang
Dec 13, 1988·European Journal of Pharmacology·J R HuR E Lang
May 12, 1988·Nature·E J Neer, D E Clapham
Apr 1, 1982·Canadian Journal of Physiology and Pharmacology·J P Morgan, J R Blinks
Jul 1, 1980·Journal of Molecular and Cellular Cardiology·R A HaworthH A Berkoff

❮ Previous
Next ❯

Citations

May 1, 1993·Clinical Cardiology·V J Dzau
Sep 2, 1998·Journal of Clinical Pharmacology·S P Glasser
Mar 24, 2007·Cellular and Molecular Life Sciences : CMLS·E M Winter, A C Gittenberger-de Groot
Jan 16, 2002·Current Hypertension Reports·David HürlimannFrank Ruschitzka
Nov 3, 1994·European Journal of Pharmacology·G Y PaikJ P Morgan
Dec 30, 1994·Biochimica Et Biophysica Acta·C A HansenJ D Robishaw
Apr 15, 1994·European Journal of Pharmacology·T R Shannon, C C Hale
Nov 1, 1992·Trends in Cardiovascular Medicine·J H Brown, E A Martinson
May 1, 1993·Trends in Cardiovascular Medicine·A M Shah, M J Lewis
Nov 1, 1996·Progress in Cardiovascular Diseases·A M ShahW J Paulus
Jan 1, 1997·Progress in Cardiovascular Diseases·J L BalligandT W Smith
Mar 20, 1998·Comparative Biochemistry and Physiology. Part A, Physiology·M A MasiniB M Uva
Nov 20, 1998·Journal of the American College of Cardiology·D SaadF G Spinale
Oct 6, 1997·British Journal of Pharmacology·H TanakaM Yoshimura
May 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·C RamaciottiS Winegrad
Apr 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·G McClellanS Winegrad
Oct 1, 1995·Clinical and Experimental Pharmacology & Physiology·L M DelbridgeP J Harris
Jun 1, 1995·Acta Physiologica Scandinavica·J OffstadS E Downing
Jan 1, 1997·Annual Review of Physiology·S Winegrad
Jun 9, 2000·Annual Review of Physiology·W R MacLellan, M D Schneider
Mar 17, 2001·Environmental Health Perspectives·Y J Kang
Jun 21, 2001·Biochemical and Biophysical Research Communications·A F JamesM J Shattock
Oct 21, 2000·Journal of Molecular and Cellular Cardiology·G WölkartF Brunner
Dec 17, 2009·The Journal of Surgical Research·Hui-min LiuZhengyuan Xia
Sep 1, 1996·Journal of Cardiac Failure·Y SetaD L Mann

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.